| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
Expenses | ||||||
Research and development expenses | ||||||
27,405 | 16,851 | 14,396 | ||||
Investment tax credits | ||||||
1,237 | 139 | 165 | ||||
Research and development expense, net | ||||||
26,168 | 16,712 | 14,231 | ||||
General and administrative expenses | ||||||
9,287 | 3,405 | 5,478 | ||||
Interest income | ||||||
1,082 | 398 | 109 | ||||
Financial expenses | ||||||
-80,437 | -37,645 | -56,140 | ||||
Net loss before income taxes | ||||||
-114,811 | -57,365 | -75,740 | ||||
Income tax expense | ||||||
643 | 146 | 156 | ||||
Net loss and comprehensive loss | ||||||
-115,455 | -57,511 | -75,896 | ||||
Basic and diluted loss per share (in dollars per share) | ||||||
-7.93 | -24.46 | -33.06 | ||||
Weighted average number of outstanding basic and diluted shares (in shares) | ||||||
14,560 | 2,351 | 2,295 | ||||